SeaStar Medical Holding Corp (ICU)
2025-06-30 | 2025-03-31 | 2024-09-30 | ||
|---|---|---|---|---|
| Net revenue | 338 | 293 | 68 | |
| Cost of goods sold | 27 | - | - | |
| Gross profit | 311 | 293 | 68 | |
| Research and development | 1,037 | 2,431 | 2,336 | |
| General and administrative | 1,030 | 1,684 | 2,188 | |
| Total operating expenses | 2,067 | 4,115 | 4,524 | |
| Loss from operations | -1,756 | -3,822 | -4,456 | |
| Interest income | 45 | 48 | 58 | |
| Interest expense | 9 | 11 | 272 | |
| Change in fair value of warrants liability | -16 | -16 | -192 | |
| Other financing costs | 298 | - | - | |
| Change in fair value of convertible notes | - | - | - | |
| Total other income (expense), net | -246 | 53 | -22 | |
| Loss before provision for income taxes | -2,002 | -3,769 | -4,478 | |
| Provision for income taxes | - | 3 | - | |
| Net loss | -2,002 | -3,772 | -4,478 | |
| Earnings per share, basic | -0.18 | -0.44 | -1.1 | |
| Earnings per share, diluted | -0.18 | -0.44 | -1.1 | |
| Weighted average number of shares outstanding, basic | 11,329,517 | 8,617,932 | 4,086,871 | |
| Weighted average number of shares outstanding, diluted | 11,329,517 | 8,617,932 | 4,086,871 | |